⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman
prnewswire.com
REGN
REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action - Contact Levi & Korsinsky
accessnewswire.com
REGN
REGN UPCOMING DEADLINE: Levi & Korsinsky Alerts Regeneron Pharmaceuticals, Inc. Stockholders of Securities Class Action - Contact the Firm
prnewswire.com
REGN
Fraud Detection and Prevention (FDP) in BFSI Market worth $15.06 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
MA
T
IBM
FIS
FISV
AXP
V
PYPL
COF
BK
BAC
JPM
WFC
C
MS
GS
SCHW
AXS
ALL
CB
PGR
TRV
UNM
MET
PRU
AIG
L
AIZ
SIGI
ENR
LNC
AGNC
IVZ
AMP
ICE
EQIX
AMZN
GOOGL
MSFT
NVDA
AMD
INTC
CSCO
ADBE
CRM
ORCL
SAP
ACN
GOOG
AMAT
MU
QCOM
TXN
INTU
ADP
PAYX
DXC
CTSH
INFY
WDC
SE
MELI
BABA
JD
NTES
PDD
BIDU
IQ
VIPS
XPEV
NIO
LI
LCID
RIVN
TSLA
GM
F
STLA
CHPT
BLNK
PLUG
FCEL
BE
RUN
SEDG
ENPH
CRSP
MRNA
BMY
PFE
JNJ
GILD
AMGN
BIIB
REGN
AZN
LLY
ABBV
XOM
CVX
SHEL
TTE
COP
EOG
APA
OXY
XNET
UPST
SOFI
HOOD
COIN
MP
EXAS
TDOC
ON
NXPI
MRVL
ALGN
IDXX
VRTX
SNPS
CDNS
MCHP
ADI
AVGO
LRCX
ASML
KLAC
TER
GPN
LXU
ACI
XPER
NICE
BCC
FEED
DV
REGENERNON PHARMACEUTICALS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 14, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
globenewswire.com
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors - Lead Plaintiff Deadline on September 14, 2026
accessnewswire.com
REGN
REGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN